Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,937
Sort by:

Parenteral Nutrition Market Size, Share and Growth Outlook 2026: By Nutrient Type, By Patient Stage, By Therapeutic Indication, By Sales and Distribution Channel, Companies to 2034

US$ 3,482.00

The global Parenteral Nutrition Market size is forecast to increase from $8.01 Billion in 2026 to $12.52 Billion in 2034 at a CAGR of 5.74% between 2026 and 2034. The Parenteral Nutrition market repor...

July 2026 190 pages

Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share and Growth Outlook 2026: By Treatment, By Route of Administration, By Patient Group, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Paroxysmal Nocturnal Hemoglobinuria Treatment Market size is forecast to increase from $6.77 Billion in 2026 to $14.03 Billion in 2034 at a CAGR of 9.54% between 2026 and 2034. The Paroxysm...

July 2026 190 pages

Peptide Antibiotics Market Size, Share and Growth Outlook 2026: By Product Type, By Disease, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Peptide Antibiotics Market size is forecast to increase from $5.62 Billion in 2026 to $8.42 Billion in 2034 at a CAGR of 5.18% between 2026 and 2034. The Peptide Antibiotics market report p...

July 2026 190 pages

Plant-based API Market Size, Share and Growth Outlook 2026: By Product Type (Amino Acids, Alkaloids, Glycosides, Flavonoids, Terpenoids, Polyphenols, Others), By Application, By Extraction Method, By End User, Companies to 2034.

US$ 3,482.00

The global Plant-based API Market size is forecast to increase from $36.67 Billion in 2026 to $59.42 Billion in 2034 at a CAGR of 6.22% between 2026 and 2034. The Plant-based API market report provide...

July 2026 190 pages

Plant-based Excipients Market Size, Share and Growth Outlook 2026: By Chemical Nature (Carbohydrates, Proteins and Amino Acids, Oleochemicals, Minerals and Others), By Functionality, By Formulation Type, Companies to 2034.

US$ 3,482.00

The global Plant-based Excipients Market size is forecast to increase from $2.23 Billion in 2026 to $3.14 Billion in 2034 at a CAGR of 4.39% between 2026 and 2034. The Plant-based Excipients market re...

July 2026 190 pages

Primary Biliary Cholangitis Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Mechanism of Action, By Line of Therapy, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Primary Biliary Cholangitis Therapeutics Market size is forecast to increase from $907.67 Million in 2026 to $1635.75 Million in 2034 at a CAGR of 7.64% between 2026 and 2034. The Primary B...

July 2026 190 pages

Shingles Vaccine Market Size, Share and Growth Outlook 2026: By Vaccine Type (Recombinant Zoster Vaccines, Live Attenuated Zoster Vaccines, mRNA-Based Zoster Vaccines), By Indication, By End Use, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Shingles Vaccine Market size is forecast to increase from $5.96 Billion in 2026 to $19.84 Billion in 2034 at a CAGR of 16.22% between 2026 and 2034. The Shingles Vaccine market report provi...

July 2026 190 pages

Synthetic Small Molecule API Market Size, Share and Growth Outlook 2026: By Molecule Type (Standard API, High Potency API (HPAPI)), By Manufacturing Model, By Application, By Therapeutic Area, By Manufacturing Scale, Companies to 2034.

US$ 3,482.00

The global Synthetic Small Molecule API Market size is forecast to increase from $188.07 Billion in 2026 to $295.48 Billion in 2034 at a CAGR of 5.81% between 2026 and 2034. The Synthetic Small Molecu...

July 2026 190 pages

Systemic Scleroderma Treatment Market Size, Share and Growth Outlook 2026: By Drug Class, By Symptom, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Systemic Scleroderma Treatment Market size is forecast to increase from $1.81 Billion in 2026 to $2.75 Billion in 2034 at a CAGR of 5.36% between 2026 and 2034. The Systemic Scleroderma Tre...

July 2026 190 pages

Transthyretin Amyloidosis Treatment Market Size, Share and Growth Outlook 2026: By Drug Type (Tafamidis (Vyndaqel), Patisiran (ONPATTRO), Inotersen (TEGSEDI), Others), By Disease Type, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Transthyretin Amyloidosis Treatment Market size is forecast to increase from $7.67 Billion in 2026 to $20.17 Billion in 2034 at a CAGR of 12.85% between 2026 and 2034. The Transthyretin Amy...

July 2026 190 pages

Immunosuppressants Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Immunosuppressants Market size is forecast to increase from $465.65 Billion in 2026 to $1347.06 Billion in 2034 at a CAGR of 14.2% between 2026 and 2034. The Immunosuppressants market repor...

July 2026 190 pages

Inflammatory Bowel Disease Market Size, Share and Growth Outlook 2026: By Disease Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Inflammatory Bowel Disease Market size is forecast to increase from $23.44 Billion in 2026 to $33.08 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034. The Inflammatory Bowel Disease...

July 2026 190 pages

Injectable Drugs Market Size, Share and Growth Outlook 2026: By Product Type, By Route of Administration, By Therapeutic Application, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Injectable Drugs Market size is forecast to increase from $723.52 Billion in 2026 to $1309.71 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034. The Injectable Drugs market report pro...

July 2026 190 pages

Interstitial Cystitis Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Type, By Route of Administration, By Formulation Type, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Interstitial Cystitis Drugs Market size is forecast to increase from $1.37 Billion in 2026 to $2.07 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034. The Interstitial Cystitis Drugs...

July 2026 190 pages

Iron Drugs Market Size, Share and Growth Outlook 2026: By Product Type (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, Ferric Gluconate, Iron Isomaltoside), By Application, By End-User, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Iron Drugs Market size is forecast to increase from $8.89 Billion in 2026 to $19.48 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034. The Iron Drugs market report provides detailed...

July 2026 190 pages

Irritable Bowel Syndrome Market Size, Share and Growth Outlook 2026: By Symptom Type, By Product, By Consumer Demographics, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Irritable Bowel Syndrome Market size is forecast to increase from $4.2 Billion in 2026 to $7.89 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Irritable Bowel Syndrome market...

July 2026 190 pages

Kidney Transplantation Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Kidney Transplantation Therapeutics Market size is forecast to increase from $10.6 Billion in 2026 to $18.76 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034. The Kidney Transplantat...

July 2026 190 pages

Krabbe Disease Treatment Market Size, Share and Growth Outlook 2026: By Therapy Type, By Disease Type, By End User, Companies to 2034

US$ 3,482.00

The global Krabbe Disease Treatment Market size is forecast to increase from $1.18 Billion in 2026 to $2.12 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034. The Krabbe Disease Treatment market...

July 2026 190 pages

Leuprolide Acetate Market Size, Share and Growth Outlook 2026: By Product Form (Immediate-Release Injection, 1-Month Depot, 3-Month Depot, 6-Month Depot, 12-Month Depot), By Application, By End-User, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Leuprolide Acetate Market size is forecast to increase from $2.83 Billion in 2026 to $5.76 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034. The Leuprolide Acetate market report prov...

July 2026 190 pages

Liver Cirrhosis Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease Indication, By Stage Type, By End User, Companies to 2034

US$ 3,482.00

The global Liver Cirrhosis Therapeutics Market size is forecast to increase from $3.52 Billion in 2026 to $7.88 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034. The Liver Cirrhosis Therapeuti...

July 2026 190 pages

Liver Disease Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease, By Route of Administration, By End User, Companies to 2034

US$ 3,482.00

The global Liver Disease Treatment Market size is forecast to increase from $22.6 Billion in 2026 to $35.75 Billion in 2034 at a CAGR of 5.9% between 2026 and 2034. The Liver Disease Treatment market...

July 2026 190 pages

LVAD (Left Ventricular Assist Device) Market Size, Share and Growth Outlook 2026: By Flow Type (Continuous Flow, Pulsatile Flow), By Design Type, By Indication, By End-User, Companies to 2034.

US$ 3,482.00

The global LVAD (Left Ventricular Assist Device) Market size is forecast to increase from $1.51 Billion in 2026 to $2.84 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Left Ventricular A...

July 2026 190 pages

mAb Biosimilars Market Size, Share and Growth Outlook 2026: By Type, By Therapeutic Application, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global mAb Biosimilars Market size is forecast to increase from $15.79 Billion in 2026 to $40.8 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034. The mAb Biosimilars market report provides...

July 2026 190 pages

Medical Mattresses Market Size, Share and Growth Outlook 2026: By Product Type (Foam Mattresses, Air Mattresses, Gel Mattresses, Innerspring Mattresses, Hybrid Mattresses), By Usability, By Distribution Channel, By End User, Companies to 2034.

US$ 3,482.00

The global Medical Mattresses Market size is forecast to increase from $8.95 Billion in 2026 to $15.26 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034. The Medical Mattresses market report pro...

July 2026 190 pages

Musculoskeletal Disorders Therapeutics Market Size, Share and Growth Outlook 2026: By Disease Type (Arthritis, Osteoporosis, Fibromyalgia, Others), By Molecule Type, By Treatment Type, By End-User, Companies to 2034.

US$ 3,482.00

The global Musculoskeletal Disorders Therapeutics Market size is forecast to increase from $224.6 Billion in 2026 to $360.69 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The Musculoskeleta...

July 2026 190 pages

Myasthenia Gravis Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Treatment Type, By Route of Administration, By End-User, Companies to 2034

US$ 3,482.00

The global Myasthenia Gravis Drugs Market size is forecast to increase from $2.82 Billion in 2026 to $5.54 Billion in 2034 at a CAGR of 8.8% between 2026 and 2034. The Myasthenia Gravis Drugs market r...

July 2026 190 pages

Neuromuscular Disease Therapeutics Market Size, Share and Growth Outlook 2026: By Disease, By Drug, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuromuscular Disease Therapeutics Market size is forecast to increase from $17.24 Billion in 2026 to $49.52 Billion in 2034 at a CAGR of 14.1% between 2026 and 2034. The Neuromuscular Dise...

July 2026 190 pages

Non-alcoholic Fatty Liver Disease Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Distribution Channel, By Age Group, By Complication Type, Companies to 2034

US$ 3,482.00

The global Non-alcoholic Fatty Liver Disease Therapeutics Market size is forecast to increase from $24.18 Billion in 2026 to $49.61 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034. The Non-alc...

July 2026 190 pages

Osteoarthritis Market Size, Share and Growth Outlook 2026: By Anatomy, By Treatment Type, By Drug Type, By Route of Administration, By Diagnosis, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Osteoarthritis Market size is forecast to increase from $10.23 Billion in 2026 to $17.45 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034. The Osteoarthritis market report provides d...

July 2026 190 pages

Osteoarthritis Pain Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Application, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Osteoarthritis Pain Drugs Market size is forecast to increase from $9.46 Billion in 2026 to $15.77 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034. The Osteoarthritis Pain Drugs mar...

July 2026 190 pages

Osteonecrosis Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Class, By Route of Administration, By Indication, By End User, Companies to 2034

US$ 3,482.00

The global Osteonecrosis Therapeutics Market size is forecast to increase from $865.33 Million in 2026 to $1475.72 Million in 2034 at a CAGR of 6.9% between 2026 and 2034. The Osteonecrosis Therapeuti...

July 2026 190 pages

Overactive Bladder Therapeutics Market Size, Share and Growth Outlook 2026: By Pharmacotherapy, By Disease Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Overactive Bladder Therapeutics Market size is forecast to increase from $4.29 Billion in 2026 to $6.29 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034. The Overactive Bladder Thera...

July 2026 190 pages

Pain Management Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Pain Management Drugs Market size is forecast to increase from $80.89 Billion in 2026 to $115.92 Billion in 2034 at a CAGR of 4.6% between 2026 and 2034. The Pain Management Drugs market re...

July 2026 190 pages

Pediatric Medicines Market Size, Share and Growth Outlook 2026: By Drug Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Pediatric Medicines Market size is forecast to increase from $156.23 Billion in 2026 to $304.51 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034. The Pediatric Medicines market repor...

July 2026 190 pages

Penicillin Market Size, Share and Growth Outlook 2026: By Source Type (Natural Penicillin, Semi-Synthetic Penicillin), By Route of Administration, By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Penicillin Market size is forecast to increase from $9.64 Billion in 2026 to $13.09 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034. The Penicillin market report provides detailed a...

July 2026 190 pages

Peptic Ulcer Drugs Market Size, Share and Growth Outlook 2026: By Product (Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs, Antibiotics), By Application, Companies to 2034.

US$ 3,482.00

The global Peptic Ulcer Drugs Market size is forecast to increase from $5.33 Billion in 2026 to $6.6 Billion in 2034 at a CAGR of 2.7% between 2026 and 2034. The Peptic Ulcer Drugs market report provi...

July 2026 190 pages

Pleurodynia Treatment Market Size, Share and Growth Outlook 2026: By Treatment Modality, By Symptoms, By Complications, By Patient Type, By Healthcare Setting, Companies to 2034

US$ 3,482.00

The global Pleurodynia Treatment Market size is forecast to increase from $115.2 Million in 2026 to $150.53 Million in 2034 at a CAGR of 3.4% between 2026 and 2034. The Pleurodynia Treatment market re...

July 2026 190 pages

Polycystic Kidney Disease Drugs Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Disease Type, By Mode of Administration, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Polycystic Kidney Disease Drugs Market size is forecast to increase from $471.51 Million in 2026 to $718.15 Million in 2034 at a CAGR of 5.4% between 2026 and 2034. The Polycystic Kidney Di...

July 2026 190 pages

Primary Immunodeficiency Diseases Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease Type, By Test Type, By Age Group, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Primary Immunodeficiency Diseases Treatment Market size is forecast to increase from $8.38 Billion in 2026 to $13.77 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034. The Primary Imm...

July 2026 190 pages

Primary Sclerosing Cholangitis Treatment Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Mechanism of Action, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Primary Sclerosing Cholangitis Treatment Market size is forecast to increase from $135.81 Million in 2026 to $214.83 Million in 2034 at a CAGR of 5.9% between 2026 and 2034. The Primary Scl...

July 2026 190 pages

Proteinuria Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Proteinuria Therapeutics Market size is forecast to increase from $1.8 Billion in 2026 to $2.93 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034. The Proteinuria Therapeutics market...

July 2026 190 pages

Proton Pump Inhibitors (PPIs) Market Size, Share and Growth Outlook 2026: By Drug Type, By Route of Administration, By Dosage Form, By Prescription Category, By Disease Indication, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Proton Pump Inhibitors (PPIs) Market size is forecast to increase from $3.87 Billion in 2026 to $5.67 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034. The Proton Pump Inhibitors mar...

July 2026 190 pages

Raloxifene Hydrochloride Market Size, Share and Growth Outlook 2026: By Product (Branded / Innovator Drugs, Generic Drugs), By Indication, By Core Industry Sector, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Raloxifene Hydrochloride Market size is forecast to increase from $2.61 Billion in 2026 to $5.24 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034. The Raloxifene Hydrochloride market...

July 2026 190 pages

Renal Anemia Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease Type, By Formulation Type, By Route of Administration, By Age Group, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Renal Anemia Therapeutics Market size is forecast to increase from $5.68 Billion in 2026 to $10.21 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034. The Renal Anemia Therapeutics mar...

July 2026 190 pages

Rickets Treatment Market Size, Share and Growth Outlook 2026: By Type, By Therapy, By Age Group, By End User, Companies to 2034

US$ 3,482.00

The global Rickets Treatment Market size is forecast to increase from $1.17 Billion in 2026 to $1.91 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034. The Rickets Treatment market report provid...

July 2026 190 pages

Sarcoidosis Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Type (Corticosteroids, Immunosuppressants, TNF-alpha Inhibitors, Antimalarials, Others), By Route of Administration, By End User, Companies to 2034.

US$ 3,482.00

The global Sarcoidosis Therapeutics Market size is forecast to increase from $334.94 Million in 2026 to $510.14 Million in 2034 at a CAGR of 5.4% between 2026 and 2034. The Sarcoidosis Therapeutics ma...

July 2026 190 pages

Sinuscope Endoscopes Market Size, Share and Growth Outlook 2026: By Product Type (Rigid Sinuscopes, Flexible Sinuscopes), By Size, By Technology, By End-User, Companies to 2034.

US$ 3,482.00

The global Sinuscope Endoscopes Market size is forecast to increase from $327.74 Million in 2026 to $593.27 Million in 2034 at a CAGR of 7.7% between 2026 and 2034. The Sinuscope Endoscopes market rep...

July 2026 190 pages

Sinusitis Drugs Market Size, Share and Growth Outlook 2026: By Disease Type (Acute Sinusitis, Sub-Acute Sinusitis, Chronic Sinusitis), By Drug Class, By Route of Administration, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Sinusitis Drugs Market size is forecast to increase from $2.54 Billion in 2026 to $4.11 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034. The Sinusitis Drugs market report provides d...

July 2026 190 pages

Small Cell Lung Cancer Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Disease Stage, By Line of Therapy, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Small Cell Lung Cancer Therapeutics Market size is forecast to increase from $10.61 Billion in 2026 to $20.68 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034. The Small Cell Lung Ca...

July 2026 190 pages

Splenomegaly Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment, By Underlying Cause, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Splenomegaly Therapeutics Market size is forecast to increase from $2.58 Billion in 2026 to $3.32 Billion in 2034 at a CAGR of 3.2% between 2026 and 2034. The Splenomegaly Therapeutics mark...

July 2026 190 pages

Filters

Search

Publishers

1
450
353
174
29
4
837
409
36
27
1,343
77
19
16
2
21
1
16
1
5
9
2,264
5
4
31
6
142
1
17
15
248
651
91
1
373
26
34
724
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
106
27
19
4
7
3
324
15
1
23
86
24
29
44
296
17
18
2

Regions

130
40
38
37
37
35
32
23
13
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
90
12
354
30
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
39
6
4
3
3
3
1
1
3
7
8,592

Price

Date

Pages

Offers

9
1